Clinical Trial Update: Evaluation of [68Ga]Ga-PentixaFor PET Imaging for the Identification of Unilateral Adrenal Secretion of ALdosterON in Patients With Primary Aldosteronism [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the PET imaging agent [68Ga]Ga-PentixaFor to identify unilateral aldosterone secretion in primary aldosteronism; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aldosteronism

Drugs mentioned

• [68Ga]Ga-PentixaFor (pentixaFor radiopharmaceutical)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Primary Aldosteronism | Phase 2 | Status: NOT_YET_RECRUITING